1040 / 1224
Author/year
# pts.
LNmet/
total
Primary
Fract x dose
Local
control
2-years
Survival
2-years
Severe
morbidity
Chawla 2009
30
16 pall.
Mixed
(lung;
n=20)
4 x 4Gy
10 x 5Gy
55%
(1-year)
44%
(1-year)
No
Holy 2011
13 (18)
NSCLC
5 x 4-8Gy
77%
50%
Grade 3 (n=2)
Casamassima
2012
48
Mixed
(lung;
n=24)
3 x 12Gy
90%
40%
No
Retrospective cohorts